Oncosec medical inc (ONCS)
Income statement / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Apr'11
Revenue

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Expenses:
Research and development

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

20,562

-

-

17,415

13,875

12,378

12,266

11,952

12,230

12,951

14,182

14,741

14,989

15,544

14,290

13,132

11,156

8,924

7,523

5,796

4,589

3,596

2,752

3,159

3,146

3,139

3,033

2,368

1,941

0

0

0

General and administrative

17,360

13,625

11,971

14,936

17,383

18,939

18,689

15,500

12,377

9,634

9,669

10,081

10,940

11,317

12,144

11,911

11,091

9,925

8,108

7,051

7,113

6,497

6,153

5,576

4,462

4,303

3,905

3,722

3,608

3,296

3,158

2,517

0

0

0

Loss from operations

-37,795

-32,751

-30,416

-35,498

-37,876

-37,681

-36,105

-29,376

-24,756

-21,901

-21,622

0

0

0

-

-

-

-

-

0

0

-

-11,949

-10,166

-8,059

-7,055

-7,064

-6,868

-6,747

-6,330

-5,527

-4,459

0

0

0

Other income, net

348

408

440

574

552

461

374

107

127

154

173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

32

52

68

83

100

155

224

266

0

0

0

-

Interest expense

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant inducement expense

-

-

-

-

-

-

-

-

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange (loss) gain, net

-331

-113

-281

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss, net

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized loss on sale of securities, net

-

-

-12

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-37,783

-32,462

-30,274

-35,202

-38,383

-40,808

-39,135

-32,594

-27,094

-21,746

-21,448

-22,112

-23,802

-25,453

-26,886

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,037

-14,029

-11,970

-10,199

-8,112

-7,124

-7,148

-6,969

-6,051

-7,101

-2,362

-1,266

0

0

0

Provision for income taxes

0

-

1

10

7

3

0

0

0

0

1

1

1

1

2

2

3

3

1

1

1

-8

41

41

40

50

2

2

2

2

2

4

0

0

0

Net loss

-37,779

-32,460

-30,276

-35,213

-38,390

-40,811

-39,136

-32,595

-27,095

-21,746

-21,449

-22,113

-23,804

-25,454

-26,888

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-1.27

-0.92

-0.56

-1.03

-1.33

-1.37

-7.20

-1.98

-0.31

-0.26

-0.28

-0.22

-0.27

-0.29

-0.37

-0.37

-0.42

-0.47

-

-

-

-0.33

-

-

-

-0.01

-

-

-

-0.02

-

-

-

-

-

Weighted average shares used in computing basic and diluted net loss per common share

10,712

10,648

9,756

6,664

6,272

5,519

-46,150

5,087

34,794

22,318

21,300

20,704

19,733

19,020

17,499

16,971

16,761

14,826

-

-

-

12,231

-

-

-

144,247

-

-

-

87,892

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-18,210

-16,039

-14,021

-12,012

-10,241

-8,153

-7,174

-7,150

-6,971

-6,053

-7,103

-2,364

-1,270

0

0

0

Basic net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.48

-0.38

-

-

-0.37

-0.01

-

-

-0.01

-0.02

-

-

-0.01

-0.05

0.05

-0.01

Diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.48

-0.38

-

-

-0.37

-0.01

-

-

-0.01

-0.02

-

-

-0.01

-0.05

0.05

-0.01

Weighted average shares used in computing basic net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,349

12,312

-

-

10,364

176,838

-

-

117,859

102,895

-

-

68,222

56,856

56,856

61,611

Weighted average shares used in computing diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,349

12,312

-

-

10,364

176,838

-

-

117,859

102,895

-

-

68,222

56,856

56,905

61,611